Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected] (Q39723710)

14 September 2017

title

Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected] (English)

1 reference

14 September 2017

Kazuhito Izukuri

1

1 reference

14 September 2017

Kenji Suzuki

2

1 reference

14 September 2017

Nobuyuki Yajima

3

1 reference

14 September 2017

Shigeyuki Ozawa

4

1 reference

14 September 2017

Shin Ito

5

1 reference

14 September 2017

Eiro Kubota

6

1 reference

14 September 2017

Ryu-Ichiro Hata

7

1 reference

14 September 2017

publication date

24 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

19

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

1109-1117

1 reference

https://scigraph.springernature.com/pub.10.1007/s11248-010-9384-7

14 September 2017

exact match

0 references

cites work

TGF-beta antagonists: why suppress a tumor suppressor?

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Putting tumours in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Genetic transformation of mouse embryos by microinjection of purified DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Chemokines, chemokine receptors, and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

The role of chemokines in cancer immune surveillance by the adaptive immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

An experimental model of tumor dormancy therapy for advanced head and neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Role of chemokines in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Modulation of CXCL14 (BRAK) expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Emerging molecular markers of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

CXCL14 expression and potential function in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

The chemokine and chemokine receptor superfamilies and their molecular evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-010-9384-7

Chemokines and their role in tumor growth and metastasis

21 January 2018

1 reference

12 December 2020

CXC chemokines in angiogenesis.

1 reference

12 December 2020

Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis

1 reference

12 December 2020

Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro

1 reference

12 December 2020

Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation

1 reference

12 December 2020

Constitutive expression of CXCL14 in healthy human and murine epithelial tissues

1 reference

12 December 2020

10.1007/S11248-010-9384-7

Identifiers

DOI

1 reference

14 September 2017

1 reference